BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24891615)

  • 1. Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells.
    Zafar A; Wu F; Hardy K; Li J; Tu WJ; McCuaig R; Harris J; Khanna KK; Attema J; Gregory PA; Goodall GJ; Harrington K; Dahlstrom JE; Boulding T; Madden R; Tan A; Milburn PJ; Rao S
    Mol Cell Biol; 2014 Aug; 34(16):2961-80. PubMed ID: 24891615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
    Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.
    Hu Y; Li S; Yang M; Yan C; Fan D; Zhou Y; Zhang Y; Yagüe E; Xiong D
    Breast Cancer Res Treat; 2014 Jan; 143(2):287-99. PubMed ID: 24337682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
    D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
    Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer.
    Boulding T; Wu F; McCuaig R; Dunn J; Sutton CR; Hardy K; Tu W; Bullman A; Yip D; Dahlstrom JE; Rao S
    PLoS One; 2016; 11(2):e0148065. PubMed ID: 26859151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
    Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
    Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
    BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2
    Xu G; Zhao H; Xu J; Zhang Y; Qi X; Shi A
    J Ethnopharmacol; 2021 Apr; 269():113705. PubMed ID: 33346025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
    Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
    J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of chromatin accessibility domains in human breast cancer stem cells.
    Hardy K; Wu F; Tu W; Zafar A; Boulding T; McCuaig R; Sutton CR; Theodoratos A; Rao S
    Nucleus; 2016; 7(1):50-67. PubMed ID: 26962893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mnt Represses Epithelial Identity To Promote Epithelial-to-Mesenchymal Transition.
    Lavin DP; Abassi L; Inayatullah M; Tiwari VK
    Mol Cell Biol; 2021 Oct; 41(11):e0018321. PubMed ID: 34460331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
    Vesuna F; Lisok A; Kimble B; Raman V
    Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.
    Qian X; Anzovino A; Kim S; Suyama K; Yao J; Hulit J; Agiostratidou G; Chandiramani N; McDaid HM; Nagi C; Cohen HW; Phillips GR; Norton L; Hazan RB
    Oncogene; 2014 Jun; 33(26):3411-21. PubMed ID: 23975425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.
    Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Menendez JA
    Cell Cycle; 2010 Sep; 9(18):3807-14. PubMed ID: 20890129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.